Genetics
Multiple Sclerosis at the Crossroads of Genetics and Metabolism: How GWAS, Polygenic Risk Scores, and Metabolites Are Reshaping Disease Biol09, Apr 2026
09, Apr 2026
Alper Bülbül
09, Apr 2026
This blog post examines multiple sclerosis through an integrated scientific framework that connects genetic susceptibility, metabolomic alterations, genome-wide association studies, and polygenic risk scores. Drawing on recent findings from peer-reviewed journals, it explains how GWAS has mapped the polygenic architecture of MS, how PRS can quantify inherited risk, and how circulating and tissue-level metabolites may illuminate causal pathways, disease activity, and progression. The article highlights the growing importance of multi-omic approaches in moving MS research toward biologically informed prediction and precision neurology.
Read more09, Apr 2026
